Portfolio (Quarterly)
Guide ↗
Trails Edge Capital Partners, LP
· CIK 0002077247| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LBRX | LB PHARMACEUTICALS INC | Healthcare | 1,523,022.0 | $49.4M | 7.85% | +204K | +15.4% | $32.45 | +46.7% |
| 2 | IMCR | IMMUNOCORE HLDGS PLC | Healthcare | 1,063,234.0 | $33.8M | 5.36% | +381K | +55.8% | $31.75 | +16.2% |
| 3 | FDMT | 4D MOLECULAR THERAPEUTICS IN | Healthcare | 2,227,917.0 | $29.6M | 4.70% | +925K | +71.0% | $13.30 | +19.0% |
| 4 | DSGN | DESIGN THERAPEUTICS INC | Healthcare | 2,001,282.0 | $29.0M | 4.60% | +1.1M | +134.9% | $14.47 | +3.6% |
| 5 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 1,110,000.0 | $24.3M | 3.85% | +408K | +58.2% | $21.86 | -10.1% |
| 6 | — | INHIBIKASE THERAPEUTICS INC | — | 9,051,318.0 | $18.4M | 2.92% | +994K | +12.3% | $2.03 | — |
| 7 | SNSE | FAETH THERAPEUTICS INC | Healthcare | 515,335.0 | $12.9M | 2.04% | +390K | +312.3% | $25.00 | -44.6% |
| 8 | — | OPUS GENETICS INC | — | 2,743,658.0 | $11.3M | 1.79% | +2.2M | +448.7% | $4.11 | — |
| 9 | SLGL | SOL-GEL TECHNOLOGIES LTD | Healthcare | 139,445.0 | $10.3M | 1.64% | +54K | +63.1% | $74.14 | +4.8% |
| 10 | IPSC | CENTURY THERAPEUTICS INC | Healthcare | 4,134,969.0 | $10.1M | 1.61% | +1.7M | +68.8% | $2.45 | -15.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%